Pulmonary Penetration of Piperacillin and Tazobactam in Critically Ill Patients

Pulmonary infections in critically ill patients are common and are associated with high morbidity and mortality. Piperacillin–tazobactam is a frequently used therapy in critically ill patients with pulmonary infection. Antibiotic concentrations in the lung reflect target‐site antibiotic concentratio...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Felton, T W, McCalman, K, Malagon, I, Isalska, B, Whalley, S, Goodwin, J, Bentley, A M, Hope, W W
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2014
Gaiak:
Clinical Trial
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4169708/
https://ncbi.nlm.nih.gov/pubmed/24926779
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/clpt.2014.131
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak